Coherus BioSciences
CHRS
#8813
Rank
$0.15 B
Marketcap
$1.29
Share price
0.78%
Change (1 day)
-24.12%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2025 (TTM): $83.56 Million USD

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is $83.56 Million USD. In 2024 the company made a revenue of $72.8 Million USD a decrease over the revenue in the year 2023 that were of $0.25 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $83.56 M14.79%
2024 $72.8 M-71.7%
2023 $0.25 B21.89%
2022 $0.21 B-35.37%
2021 $0.32 B-31.37%
2020 $0.47 B33.63%
2019 $0.35 B
2018 N/A-100%
2017 $1.55 M-99.18%
2016 $0.19 B532.82%
2015 $30.04 M-3.42%
2014 $31.1 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
$0.11 B 38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
$0.37 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$35.97 B 42,943.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$0.70 B 747.08%๐Ÿ‡บ๐Ÿ‡ธ USA